GlaxoSmithKline: Turning a Corner in Q1
The evidence of the optimistic recovery plan at GSK is borne out in the first-quarter results and management have gone…
9 years ago
Robert Sutherland Smith
Market Tactics Ahead of the Brexit Vote
The market now resembles one of those challenging Harold Pinter plays where the dialogue of the characters is mysteriously compelling…
9 years ago
Land Securities: 21% Discount Could Narrow on a ‘Remain’ Vote
Here, I outline the success of the company in riding the London commercial boom and largely arranging things suitably, in…
9 years ago
Brexit: Caveat Emptor!
Market Latin: ‘caveat emptor’ says the Governor; ‘Et tu Brute’ rejoin shocked British Brexiteers; ‘Quo Vadis?’ shout investors. Will a…
9 years ago
Plenty More Puff in Imperial Brands
At 3,783p a share, Imperial Brands offers an estimated strongly increasing dividend payout, giving an equally attractive estimated dividend yield…
9 years ago
President Trump
In the words of Bob Dylan, ‘the times, they are a changing’ Sitting through Donald Trump’s speech after the results…
9 years ago
Recovery in Play at Barclays?
Since this is the month for quoting Shakespeare, I point out that although a rose may smell just as sweet…
9 years ago
Better Times Ahead for BP?
The first quarter results from BP are essentially good news, although complex in analysis. Here is my “hot towel around…
9 years ago
Still Flying High at IAG
I have taken another look at International Consolidated Airlines Group, which has come down 15% from 619p last December to…
9 years ago
GKN Driving Ahead
GKN (GKN) bounced cheerfully at the Trading Statement. But on first inspection it is difficult to discern what it was…
9 years ago